Riskpilot← Back to searchSign inGet full accessAB Victoriakliniken
ABActiveOrg 5566334784Rösundavägen 4Medical specialists activities · NACE 8622Est. 200220-49 employees
Revenue 2024
SEK 48,1M
+18% vs 2023
EBITDA margin
31.7%
+29% vs 2023
Equity ratio
45.2%
Financial strength
Net profit 2024
SEK 9,6M
+46% vs 2023
| Revenue | SEK 48,1M | +18% |
| EBITDA | SEK 15,2M | +29% |
| Net profit | SEK 9,6M | +46% |
| Total assets | SEK 58,8M | -5% |
| Equity | SEK 26,6M | -24% |
| Employees | — | — |
Legal name
AB Victoriakliniken
Org number
5566334784
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 oktober 2002
Share capital
SEK 100 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva plastikkirurgi, sjukvårdsverksamhet samt köpa och försälja sjukvårdsprodukter, förvalta aktier och andra värdepapper samt därmed förenlig verksamhet.
Address
Rösundavägen 4
Phone
+46853021000
Email
malin.wahlstrom@victoriakliniken.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 32 728 | 33 781 | 33 953 | 40 918 | 48 112 |
| Staff expenses | — | — | — | −11 368 | — |
| EBITDA | 10 595 | 13 494 | 9 814 | 11 780 | 15 241 |
| Depreciation & amort. | −865 | −1 166 | −1 166 | −1 166 | −1 588 |
| EBIT | 9 730 | 12 328 | 8 648 | 10 614 | 13 653 |
| Net financials | −8 | −179 | −109 | 127 | 440 |
| Profit before tax | 6 849 | 7 638 | 7 357 | 8 377 | 12 240 |
| Tax | −1 605 | −1 638 | −1 518 | −1 819 | −2 640 |
| Net profit | 5 244 | 6 000 | 5 839 | 6 558 | 9 600 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 38 063 | 50 318 | 56 944 | 62 025 | 58 814 |
| Equity | 19 694 | 25 694 | 28 582 | 35 140 | 26 575 |
| Long-term debt | 3 636 | 3 406 | 3 416 | 3 284 | 3 141 |
| Short-term debt | 7 469 | 10 811 | 13 012 | 9 303 | 12 946 |
| Total debt | 11 105 | 14 217 | 16 428 | 12 587 | 16 087 |
EBITDA margin
31.7%
This company
15.8%
Market median
+101% vs market
20202024
Equity ratio
45.2%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
36.1%
This company
18.4%
Market median
+96% vs market
20202024
Net profit margin
20.0%
This company
8.1%
Market median
+147% vs market
20202024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
1.21×
This company
0.62×
Market median
-95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LH Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Deifiera Sundsvall AB
AB Victoriakliniken Board members of AB Victoriakliniken also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Håkan Uddström | Audit | 0 companies |
| Charles Max Rickard Randquist | Board of Directors | 0 companies |
| Yvette Susann Randquist | Deputy Board Member | 0 companies |